Introduction
Hexamethylen-bisacetamide (HMBA) represents the prototype of a group of hybrid polar compounds which are dierentiation inducers for a variety of transformed cells human embryonal carcinoma NT2/ D1 cells (Marks et al., 1987; Andrews et al., 1990; Richon et al., 1996) . Several phase I studies have been performed to determine the optimal HMBA dose in the treatment of patients with both hematological and solid malignancies (Young et al., 1988; Conley et al., 1992) . A phase II study showed that HMBA infusion induced partial or complete remission in several patients aected with acute myelogenous leukemia or myelodysplastic syndrome (Andree et al., 1992) .
Although the biological eects exerted by HMBA have been extensively analysed, the cellular targets of the antiproliferative activity of HMBA and of its derivatives have been poorly de®ned. Embryonal carcinoma cells (i.e. the NT2/D1 cells) represent a suitable model to investigate the targets of antiproliferative activity exerted by HMBA (Andrews et al., 1990) . Treatment of NT2/D1 cells with HMBA results in a strong growth inhibition and in a typical morphological dierentiation, accompanied by altered expression of surface dierentiation markers such as SSEA-3, A2B5 and VINIS-53 (Andrews, 1984; Andrews et al., 1990) .
In eukaryotic cells, proliferation and dierentiation often represent mutually exclusive pathways. Factors determining whether cells continue to proliferate or arrest growth and terminally dierentiate appear to operate during the G1 phase of the cell cycle (Sherr, 1994) . G1 progression is controlled by a family of protein kinases, the cyclin-dependent kinase (CDKs), and by their corresponding active partners, the G1 cyclins. It is commonly known that cyclin D/CDK4-6 and cyclin E/CDK2 complexes play an essential role in G1-S transition (Hunter and Pines, 1994) . CDK activity is negatively regulated by inhibitory proteins de®ned as CDK inhibitor proteins (CKI) (Sherr and Roberts, 1995) . Two classes of CDK inhibitors have been identi®ed: the INK4 proteins (p15, p16, p18 and p19), which are speci®c for the cyclin D-CDK4/CDK6 complexes and the Kip/Cip inhibitors (p21, p27 and p57), which are capable of inhibiting all cyclin-CDK complexes. The Kip/Cip family comprises p21, p27 and p57 (Polyak et al., 1994; El-Deiry et al., 1993) . Both p21 and p27 are able to arrest the growth of cells in the G1 phase of the cell cycle (Polyak et al., 1994; El-Deiry et al., 1993; Coats et al., 1996) . Furthermore, increased expression of CDK inhibitors including p27, with a reduction in the overall amount of G1 CDK activity has been associated with dierentiation of various cell types (Firpo et al., 1994; Kiyokawa et al., 1996; Liu et al., 1996) .
In this study we have investigated the molecular mechanisms whereby HMBA induces growth arrest and dierentiation in embryonal carcinoma NT2/D1 cells. Here, we report that p27 plays a key role in HMBA signaling that cannot be replaced by the related CKI p21; in addition, our results demonstrate that the inhibition of CDK2 activity, either through chemical compounds or through use of a dominant negative mutant, is sucient for growth arrest but not for induction of dierentiation. Altogether, these ®ndings suggest that a function independent of CDK2 inhibition regulates terminal dierentiation in NT2/D1 cells.
Results

HMBA induces G1 arrest and terminal dierentiation in NT2/D1 cells
HMBA treatment induces growth arrest of NT2/D1 cells with accumulation of cells in G1 phase starting from 12 h of treatment as determined by¯ow-cytometry. The G1 arrest is almost complete after 24 h (Figure 1a ). HMBA induces also terminal dierentiation in NT2/D1 cells, with typical morphological changes and modi®cations of surface antigens (Andrews et al., 1990) . Untreated NT2/D1 cells express glycolipid stage-speci®c embryonic antigens of the globo-series (SSEA-3 and SSEA-4) (Shevinsky et al., 1982) whereas dierentiated NT2/D1 cells lose this expression and express glycolipidic antigens of the lacto-(SSEA-1) and ganglio-series (GT3 and GD3 recognized by the A2B5 and ME311 antibodies, respectively) or glycoproteic antigens such as those recognized by the VINIS-53 antibody (Andrews, 1984; Andrews et al., 1990) . In this study we used the antibody that recognizes the antigen SSEA-3 for undierentiated cells and the VINIS-53 Mab for cells induced to dierentiate by HMBA. Following HMBA treatment, SSEA3 expression diminished from 78 to 3% while cells positive for VINIS-53 raised from 1 ± 94% (data not shown).
Expression of cyclins and CDKs during HMBA-induced dierentiation
First we determined the protein levels of cyclins and CDKs in NT2/D1 cells induced to dierentiate with HMBA ( Figure 1b) . Among G1 cyclins, both cyclins kip1 and embryonal carcinoma cell differentiation G Baldassarre et al D1 and D2 were detected in proliferating NT2/D1 cells whereas cyclins D3 and E were expressed at low levels. HMBA induced no change in the expression of cyclin D1 and D2 whereas it increased the expression of cyclins D3 and E from 12 ± 18 h. Since cyclins D3 and E are periodically expressed in a speci®c G1 window (mid and late G1, respectively) we concluded that the accumulation of such cyclins could be due to the block of progression through G1 induced by HMBA. Conversely, the expression of the S phase cyclin (cyclin A) and the M phase (cyclin B) cyclin was reduced at 18 ± 24 h, most likely as a consequence of the reduced number of cells in the S and M phases, respectively. No change was detected in the expression levels of CDK1, CDK2, CDK4, CDK6 and CDK7 in cells treated with HMBA.
Expression of CKIs during HMBA-induced dierentiation
Western blot analysis demonstrated that p27 protein started to increase 6 h after HMBA treatment reaching a maximum at 24 h with an increase of sevenfold ( Figure 1c ). p27 accumulation preceded HMBAinduced G1 arrest as indicated by the kinetics of p27 expression relative to cell-cycle distribution (after 6 h of HMBA treatment when most cells are still proliferating), thus providing experimental support to the idea that p27 accumulation is one of the key events of HMBA-induced growth arrest of NT2/D1 cells and not simply a by-stander eect. Moreover, the ®nding that the expression of other CDK inhibitors such as p21, p57 and p16 was not changed by HMBA indicated a speci®c role for p27 in growth inhibition induced by HMBA.
The expression of p27 may be regulated at the mRNA (Liu et al., 1997) or at the protein level (Pagano et al., 1995) . Northern blot analysis suggested that HMBA did not regulate p27 expression in NT2/ D1 cells at the mRNA level as we failed to ®nd changes in the levels of p27 mRNA in HMBA-treated cells compared to control cells (Figure 1d ), suggesting that p27 accumulation after HMBA treatment was due to some post-translational mechanisms.
Eects of HMBA on retinoblastoma (pRB) protein phosphorylation
The retinoblastoma susceptibility gene product p105 RB exerts a key role in mediating cell cycle arrest and/or terminal dierentiation. The mechanism currently proposed is that pRB bind the members of the E2F transcription factor family and repress E2F-dependent transcription, this resulting in growth arrest. Only underphosphorylated pRB binds E2F and eciently blocks G1-S transition. pRB phosphorylation by activated cyclin/CDK complexes occurs during G1 and results in the release of E2F and inability to block G1 to S transition (Weinberg, 1995; Kranenburg and Zantema, 1995) . We determined the expression and the status of pRB in NT2/D1 cells after HMBA treatment (Figure 2a ). pRB level was not grossly modi®ed by HMBA; however, hypophosphorylated p105 protein accumulated after 18 ± 24 h of HMBA treatment and was almost the unique form after 24 h (80% of pRB molecules were underphosphorylated at 24 h). These results suggest that HMBA may induce G1 arrest of NT2/D1 cells through a mechanism that involves accumulation of pRB in the hypophosphorylated state. Eects of HMBA on the activity of CDKs pRB phosphorylation during G1 is regulated by the activity of several G1 cyclin/CDK complexes (cyclins D/CDK4, D/CDK6, E/CDK2, A/CDK2) (Weinberg, 1995; Sherr and Roberts, 1995) , which regulate entrance into S phase. Although the activation of several G1 cyclin/CDK complexes has been shown to be necessary for progression into the S phase, previous studies have shown that growth arrest and terminal dierentiation may occur by inhibition of either CDK2 or CDK4 kinases (Dobashi et al., 1995; Kiyokawa et al., 1994) . To identify the G1 cyclin/CDK complex targeted by HMBA during dierentiation, we examined the kinase activity associated with CDK2 or CDK4 in extracts of NT2/D1 cells induced to dierentiate by HMBA. When compared to control NT2/D1 cells, CDK2 activity in HMBA-dierentiated cells was signi®cantly reduced at 12 ± 18 h ( Figure 2b ) whereas CDK4 activity was not modi®ed by 6 ± 24 h of HMBA treatment ( Figure 2c ). In agreement with the results obtained with CDK2, cyclin E-associated kinase activity was markedly reduced after HMBA treatment ( Figure 2d ). These results demonstrated that the cyclin/ CDK complex targeted during HMBA-induced growth arrest and commitment to terminal dierentiation was basically the cyclin E/CDK2 complex.
p27 protein increases in CDK2 and cyclin E complexes immunoprecipitated from HMBA-treated NT2/D1 cells
We predicted that the increased levels of p27 observed in HMBA-treated cells should re¯ect an increased amount of p27 associated to cyclin E and CDK2. As expected, we found that signi®cantly higher levels of p27 were associated to CDK2 in NT2/D1 cells treated with HMBA compared to exponentially proliferating cells ( Figure 2b ). To normalize for the amount of immunoprecipitated CDK2, the same blots were then reprobed with anti-CDK2 antibodies. HMBA increased the amount of p27 associated to CDK2 of 3.5-fold after 12 h, ®vefold after 18 h and 5.6-fold after 24 h. Conversely, HMBA induced no change in the association of p27 to CDK4 (Figure 2c, upper panel) . HMBA also induced increased association of p27 to cyclin E (1.6-fold at 12 h, 2.9-fold at 18 h and 4.5-fold at 24 h, respectively) ( Figure 2d ). In conclusion, these ®ndings demonstrate that the increased p27 expression induced by HMBA in NT2/D1 cells results in increased association of p27 to CDK2 but not to CDK4, in agreement with the ®nding that HMBA reduces CDK2 activity but not CDK4 activity.
p27 expression is necessary for HMBA-induced dierentiation of NT2/D1
To obtain direct evidence that p27 is a necessary component of the cellular machinery that transduces HMBA signaling, we investigated the eects of HMBA on NT2/D1 cells in the presence of antisense oligodeoxynucleotides which blocked p27 synthesis. Two dierent antisense oligonucleotides against the 5' region (p27-AS1) or the middle (p27-AS2) region of p27 coding sequence were used to suppress HMBAinduced p27 expression. Same dose of a control oligonucleotide (p27-MS) with similar base composition but random sequence had no eect ( Figure 3a ). All oligonucleotides (p27-AS1, p27-AS2 and p27-MS) had no eect on the expression of the CDK2 protein ( Figure 3a ). In antisense-treated cells, the amount of CDK2-bound p27 was almost abolished and the corresponding CDK2 activity increased of 2 ± 3-fold ( Figure 3b ). In all the antisense experiments described in this section similar results were obtained with p27-AS1 and p27-AS2, thus we will refer to p27-AS for both oligonucleotides.
When NT2/D1 cells were induced to dierentiate by HMBA in the presence of 1 mM p27-AS for 2 days the number of cells decreased and there was a corresponding increase in the percentage of non-viable cells determined by trypan-blue exclusion assay (Table 1) . We determined whether cell death could be due to an The antisense experiments were performed using phosphorothioate oligodeoxynucleotides against p27 (p27 AS) or a control oligonucleotide with a scrambled sequence (p27 MS) at a ®nal concentration of 1 mM. HMBA was used at a ®nal concentration of 5 mM for 24 h. The oligodeoxynucleotides treatment started 2 h before HMBA addition to the culture medium. kip1 and embryonal carcinoma cell differentiation G Baldassarre et al apoptotic mechanism. Flow-cytometric analysis of NT2/D1 cells induced to dierentiate by HMBA in the presence of p27-AS showed that a consistent fraction (32.3%) of cells was detected in the sub-G1 population whereas cells treated with HMBA or HMBA and p27-MS (at the same concentration) presented no mroe than 6.5% of cells in the sub-G1 population ( Figure 4a and Table 1 ). Interestingly, surviving p27-AS treated cells showed increased S phase compared to MS treated cells (13.7 versus 6% of S phase, respectively). Similar results were obtained with use of NT2/D1 cells stably expressing a p27 antisense construct (unpublished results). Staining of cell nuclei with Hoechst 33258 revealed the typical nuclear fragmentation of apoptosis only in cells treated with HMBA and p27-AS but not in untreated cells, in cells treated with HMBA alone, with p27-AS alone, or in cells treated with HMBA and p27-MS ( Figure 4b and Table 1) . Finally, TUNEL assay demonstrated that an average of 5 ± 12 apoptotic cells out of 100 were detected in control cells whereas 36/100 apoptotic cells on average stained positive for terminal transferase activity when NT2/D1 cells were treated with HMBA and p27-AS for 24 h (Figure 4c ). These ®ndings demonstrate that p27 expression is necessary for proper HMBA signaling. Recent evidence suggests that cell cycle and apoptosis may be interconnected (Gil-Gomez et al., 1998) as apoptosis regulatory proteins have been shown to impinge on cell cycle machinery (O'Reilly et al., 1996; Levkau et al., 1998) . To investigate whether the suppression of HMBA-induced p27 upregulation aected the expression or the activity of known apoptosis regulatory genes we analysed the expression of Bcl-2 and Bcl-x in NT2/D1 cells treated with HMBA in the presence or in the absence of p27 antisense oligonucleotides. Western blot analysis showed that the expression of Bcl-2, which was not modi®ed in NT2/D1 cells by HMBA, was decreased in the p27AS-treated cells starting from 12 h of HMBA treatment and with marked decrease at 24 h of HMBA treatment, thus correlating with kinetics of apoptosis of p27AS-treated cells. Conversely, Bcl-x expression was not modi®ed by HMBA treatment in p27AS cells (Figure 4d) . These ®ndings suggest a mechanism whereby the suppression of p27 expression may favor resistance to the growth inhibitory eects of HMBA and/or induce apoptosis in HMBA-treated cells.
p27 and p21 induce growth arrest of NT2/D1 cells but only p27 induces the expression of surface antigens elicited during HMBA-induced dierentiation
To investigate the eects of constitutive p27 expression into NT2/D1 cells, we produced a recombinant EGFp27 protein by fusing p27 cDNA in frame with the auto¯uorescent protein Eukaryotic Green Fluorescent Protein (EGFP) (Chal®e et al., 1994) . As control of the speci®c dierentiative action of p27, we used the pEGF-p21 construct, which encodes a recombinant EGF-p21 protein. NT2/D1 cells were transfected with pEGFP, pEGF-p27 or pEGF-p21, respectively, and analysed for growth inhibition and expression of dierentiation markers.
Cells expressing EGF-p27 or EGF-p21 proteins showed nuclear localization of green¯uorescence whereas EGFP-expressing cells showed cytoplasmic kip1 and embryonal carcinoma cell differentiation G Baldassarre et al ¯uorescence. Green nuclear¯uorescence was accompanied by an increase in p27-and p21-speci®c staining compared to pEGFP-transfected cells revealed through indirect immuno¯uorescence (Figure 5a ). In pEGFp27-transfected cells, EGF-p27 associated to CDK2 whose kinase activity was reduced compared to pEGFP-transfected cells ( Figure 5b) ; EGF-p21 associated to CDK2 whose activity was reduced compared to pEGFP-transfected cells (Figure 5c ). Such results demonstrated that both recombinant proteins were expressed at similar levels, retained the ability to translocate into cell nuclei, bound cyclin/CDK2 complexes and reduced the kinase activity thereof.
Both pEGF-p27 and pEGF-p21 induced a drastic inhibition in the BrdU uptake of NT2/D1 cells. Table 2 summarizes these results. Cells transfected with pEGFP showed 7% of inhibition whereas EGF-p27-expressing cells showed 88% of inhibition and EGF-p21-expressing cells showed 84% of inhibition. A representative experiment is reported in Figure 6a . When assayed for dierentiation, we found that pEGFP and pEGF-p21 were unable to modify the expression of both surface antigens (SSEA-3 and VINIS-53); conversely the transfection of pEGF-p27 determined a marked down-regulation of SSEA-3 and increased expression of VINIS-53. Immuno¯uorescence analysis of surface antigens in cells expressing EGFP, EGF-p27 or EGF-p21 revealed that 69% of pEGFP-transfected NT2/D1 cells and 62% of pEGF-p21-transfectd NT2/D1 cells expressed SSEA-3 whereas only 12% of pEGF-p27-transfected NT2/D1 cells retained expression of this antigen. Expression of surface antigen recognized by VINIS-53 revealed that about 44% of NT2/D1 cells expressing the EGF-p27 protein produced the same antigen recognized by VINIS-53 whereas no modi®cation in the expression pattern of VINIS-53 was observed in cells transfected with pEGF-p21 or pEGFP alone. These experiments were repeated four times and Table 2 shows the mean+s.d. of the results obtained. Similar results were obtained with CMV-based constructs (pCMV-p27, pCMV-p21 and pCMV). Results are reported in Table 2 . Figure  6 shows a representative immuno¯uorescence experiment. Altogether these results showed that the constitutive expression of p27 but not of p21 in NT2/D1 cells was sucient to elicit the same molecular events triggered by HMBA, indicating that p27 but not p21 represents a major nuclear target on which HMBA signaling impinge in the regulation of growth and dierentiation.
Inhibition of CDK2 activity per se is not sucient to induce cell dierentiation in NT2/D1 cells
We also determined whether the inhibition of CDK2 activity was sucient to induce cell dierentiation. To this aim, NT2/D1 cells were treated with 0.1 mM purine analogue inhibitor olomucine for 6, 12, 24, and 48 h and analysed for growth rate by¯ow-cytometry, BrdU incorporation and for dierentiation by immuno¯uorescence analysis of SSEA-3 expression. Olomucine-treated NT2/D1 cells started to accumulate in G1 as early as 6 ± 12 h and cells (69% of cells were in G1 after 12 h compared with 31% of DMSO treated cells) (Figure 7a ). Inhibition of S phase entry induced by olomucine was con®rmed by BrdU incorporation analysis (Table 2) . As expected, CDK2 activity was reduced drastically at 12 h of olomucine treatment, and was completely abolished at 48 h kip1 and embryonal carcinoma cell differentiation G Baldassarre et al (Figure 7b ). G1 arrest was followed by massive apoptosis at 12 ± 24 h as determined by¯ow cytometry, morphology and TUNEL assay (37% at 12 h, 69% at 24 h) and 65% at 48 h) with surviving cells blocked preferentially in S or G2/M phase ( Figure 7a ). However, when analysed for the expression of the dierentiative markers, we found that SSEA-3 expression was modi®ed neither at 24 h nor at 48 h of olomucine treatment (Figure 7d) . Results are summarized in Table 2 . Similar results were obtained by use of 10 mM of the related compound roscovitine (not shown). Finally, we inhibited CDK2 in a more selective manner by transfecting a dominant negative (DN) mutant of CDK2 (D145?N), which has been shown to completely abrogate CDK2 activity (van den Heuvel and Harlow, 1993) . In indirect immuno¯uorescence experiments, we identi®ed HA-CDK2DN-transfected cells by green staining of HA antibodies and BrdU or SSEA-3 with red staining, we found that speci®c inhibition of CDK2 by CDK2DN inhibited BrdU incorporation of NT2/D1 cells (more than 70% of inhibition) but failed to down-regulate SSEA-3 expression (Table 2 ). These ®ndings indicated that CDK2 inhibition is sucient for growth arrest of 
Discussion
In this paper we provide several evidences that point to a key role of p27 in HMBA signaling pathway. First, growth arrest and dierentiation of NT2/D1 cells induced by HMBA involve increased expression of p27 but not of other CDK inhibitors, which suggest that both anti-mitogenic and dierentiative eects of HMBA are mediated by p27. The increase in p27 expression precedes G1 accumulation of NT2/D1 cells induced by HMBA, suggesting the existence of a causal relationship between p27 accumulation and growth arrest (p27 increases after 3 ± 6 h of HMBA treatment whereas cells began to accumulate in G1 after 12 h). Second, experiments of p27 deletion by antisense oligonucleotides demonstrated that p27 is dispensable in proliferating cells but is strictly required for both growth arrest and dierentiation to occur. In fact, inhibition of HMBA-induced p27 up-regulation resulted in massive cell death after 24 ± 40 h of treatment due to the failure of the cells to arrest growth and to progress along the dierentiative pathway properly once that the dierentiation program had been triggered. Detection of terminal transferase activity and of cells with fragmented nuclei and/or condensed chromatin (the so-called apoptotic bodies) demonstrates that in the absence of p27, HMBA-treated cells undergo apoptosis. Interestingly, surviving p27-depeleted cells showed increased proliferation rate compared to untreated cells, both in cells treated with p27-AS oligonucleotides (Figure 4a ) and in NT2/D1 cells stably expressing a p27 antisense construct (not shown), suggesting a key role for p27 in the growth inhibitory pathway activated by HMBA.
Finally we demonstrated that the enforced expression of p27 into exponentially proliferating NT2/D1 cells inhibits progression into S phase and induced morphological and biochemical modi®cations such as downregulation of SSEA-3 and up-regulation of the surface antigen recognized by VINIS-53 Mab, thus partially reproducing the dierentiative eects exerted by HMBA.
Most important, it appears that the dierentiative eect exerted by p27 in NT2/D1 cells is not mere consequence of a block in the cell cycle as transfection of the related CDK inhibitor p21 into NT2/D1 cells induced growth arrest but not biochemical or morphological dierentiation. Likewise, inhibition of CDK2 by use of a CDK2 dominant negative or treatment with the purine analogue olomucine induces growth arrest and apoptosis but not dierentiation. Altogether, these ®ndings provide clear experimental support to the concept that p27 plays a key role in HMBA anti-mitogenic and dierentiative signaling, which cannot be replaced by the related p21. The results obtained with p21 and CDK2 inhibitors have several important implications. Although withdrawal from cell-cycle is a prerequisite for terminal differentiation in several cell types, in NT2/D1 cells growth arrest per se is not sucient to trigger the dierentiation program. Moreover, it appears that in NT2/D1 cells the pathways that regulate cell growth and terminal dierentiation are distinct, since inhibition of CDK2 activity (i.e. by p21, chemical inhibitors or CDK2DN, respectively) is sucient to induce growth arrest but not to trigger dierentiation. On this basis, suppression of CDK2 activity induced by increased association of p27 to cyclin E/CDK2 complexes may account only for the anti-proliferative but not for the dierentiationinducing activity exerted by HMBA. This conclusion raises the possibility that some yet unknown p27 functions, dierent from its CDK inhibitory activity, may regulate cell dierentiation in NT2/D1 cells. Consistently, it has been recently reported that p21 is able to regulate dierentiation of primary keratinocytes by a mechanism independent of its CDK inhibitory activity (Di Cunto et al., 1998) . In agreement with previous studies the results described here point to a dierential role of CDK inhibitors in cell differentiation, with p16, p21 and p27 playing dierent roles in a tissue-speci®c manner (Guo et al., 1995; Liu et al., 1996; Missero et al., 1996; Casaccia-Bonne®l et al., 1997; Di Cunto et al., 1998) . The data presented here for p27 are consistent with the conclusion that in NT2/D1 cells, p27 functions at a critical switch point where growth-arrest is followed either by dierentiation or by programmed cell death. Enforced p27 expression induces growth arrest followed by dierentiation whereas loss of HMBAdependent p27 up-regulation favors apoptosis. This protecting role has already been suggested for other CDK inhibitors but not for p27 (Poluha et al., 1996; Wang and Walsh, 1996) . On the contrary, p27 adenoviral-mediated gene transfer has been shown to induce apoptosis in several cell lines (Wang et al., 1997) . Such discrepancy may be explained by two considerations. One is that dierent mechanisms appear to regulate apoptosis in resting or cycling cells (Meikrantz and Schlegel, 1995) ; deregulated activation of CDKs results in apoptosis in resting thymocytes (Gil-Gomez et al., 1998) whereas CDK inhibition by purine analogues induces apoptosis in cycling cells (Schutte et al., 1997) . Accordingly, we found that both olomucine and CDK2DN induced apoptosis in cycling NT2/D1 cells in parallel with CDK2 inactivation. Second, it appears that p27 overexpression does not induce apoptosis (Craig et al., 1997;  this study) or presents much delayed apoptosis if cells have prior accumulated in G1 (Wang et al., 1997) . In NT2/D1 cells we found that p27-dependent G1 arrest is followed by dierentiation but not by apoptosis.
Therefore, we propose that programmed cell death may result from activation of pathways that promote apoptosis upon inappropriate expression of cell cycle regulatory molecules, as is the case of CDK2 activation in quiescent cells and CDK2 inactivation (i.e. by olomucine or CDK2DN) in cycling cells. In NT2/D1 cells, where p27 plays a role in cell dierentiation, inappropriate p27 depletion is followed by cell death. The absence of p27 could not aect apoptosis through failure of CDK2 inhibition and/or by activation of pathways that promote programmed cell death. Recent work have suggested that apoptosis regulators and cell cycle regulatory molecules are strictly interconnected (Gil-Gomez et al., 1998) . Intriguingly, we found that in HMBA-treated p27AS cells but not in control NT2/D1 cells, the expression of the Bcl-2, a gene that protects cells from apoptosis (Sentman et al., 1991; White, 1996) is reduced, suggesting that p27 and Bcl-2 lies on the same pathway. The coordination of Bcl-2 and p27 expression in HMBA-treated NT2/D1 cells may ensure that G1 arrested cells may survive and undergo terminal dierentiation. Depletion of p27 with consequent inappropriate activation of CDK2 may lead to phosphorylation of Bcl-2, which may contribute to the loss of Bcl-2 expression after 24 h of HMBA treatment and thus trigger the apoptotic pathway.
In conclusion we report that p27 plays a key role in the pathway activated by HMBA in embryonal carcinoma cells that cannot be replaced by p21. p27 but not p21 or p57 is induced by HMBA; antisense inhibition of p27 synthesis in cells induced to dierentiate by HMBA results in programmed cell death; enforced expression of p27, but not of p21, in NT2/D1 cells blocks entrance in the S phase and induces dierentiation. Therefore, we propose that p27 upregulation represents a crucial event in the HMBA signaling pathway and that CDK2 kinase inhibition, though sucient for growth arrest, is not sucient for cell dierentiation, suggesting the existence of dierent pathways that regulate growth and dierentiation.
Materials and methods
Cell culture and treatments
NT2/D1 cells were grown in Dulbecco's modi®ed Eagle medium (Sigma) supplemented with 10% of fetal calf serum (Sigma), 4 mM glutamine, 100 U/ml penicillin and 10 ng/ml streptomycin. Dierentiation of NT2/D1 cells by HMBA was performed as previously described (Baldassarre et al., 1997) . Olomocine and roscovitine treatment was performed as previously described (Alessi et al., 1998) . 
RNA extraction, Northern blotting and hyrbidization
Isolation of total cellular RNA and Northern blot were performed as described previously (Sambrook et al., 1992) . All cDNA probes were radio-labeled with a random prime synthesis kit (Amersham Inc.). The probes used in this study are the coding reegion of the human p27 cDNA and the coding region of the human GAPDH cDNA obtained by RT ± PCR.
Antibodies, protein extraction and Western blot
The antibodies used in this work were obtained from Santa Cruz Inc. (anti-cyclin D3 C-16 anti-cyclin D1 HD11, antip27 kip1 and embryonal carcinoma cell differentiation G Baldassarre et al cyclin D2 C-17, anti-Bcl-2, anti-Bcl-x and anti-p57), Oncogene Science (anti-cyclin A Ab-2; anti-p21 Ab-1), Pharmingen (anti-cyclin B1, anti-cyclin D1, anti-cyclin E HE12, and anti-pRB G3-245; anti-cyclin A BF638 and anticyclin E HE67) and Transduction Laboratories (anti-p27; anti-CDK2). Cells were scraped and lysed in cold NP-P40 buer (0.5% NP-40, 50 mM HEPES pH 7, 250 mM NaCl, 5 mM EDTA). Proteins were separated and transferred to nitrocellulose membranes (Hybond C, Amersham Inc.), revealed by the speci®c antibody and visualized using enhanced chemiluminescence (ECL, Amersham Inc.).
Immunoprecipitation and kinase assay
Four hundred micrograms of proteins were immunoprecipitated twice with 1 ± 2 mg of the indicated antibodies for 60 min at 48C. Immunoprecipitated proteins were collected on protein A/G-Sepharose (Santa Cruz), resolved on SDS ± PAGE, transferred to nitrocellulose ®lters and incubated with primary antibodies. One tenth of immunoprecipitates were resuspended in kinase buer and kinase assays were performed as previously described (Polyak et al., 1994) using 2 mg of Histone H1 (Upstate Biotechnology) or 1 mg of GST-pRB 769 (Santa Cruz Inc.) as substrates. Analysis of gels was performed using a Phosphorimager (GS-525 Biorad) interfaced with Hewlett-Packard computer.
Vectors and transfections
p27 and p21 cDNAs were obtained by RT ± PCR (pCMVp27 and pCMV-p21) using primers chosen according to published cDNA sequences (Polyak et al., 1994; El-Deiry et al., 1993) and cloned in frame in the EcoRI ± BamHI sites of pEGFP-C (Clontech Inc.). Correct cloning was con®rmed by sequencing. NT2/D1 cells were transfected as follows: 2610 6 cells were seeded in 100-mm dishes. The day after, cells were transiently transfected with pEGFP or pEGF-p27 using the DOTAP liposomal transfection reagents (Boehringer Mannheim Biochemicals). Forty-eight hours post-transfection, cells were scraped in ice-cold PBS and lysed in NP-40 lysis buer or processed for indirect immuno¯uorescence.
Immuno¯uorescence analysis
BrdU incorporation assay was performed using BrdU labeling and detection kit (Boehringer Mannheim Biochemicals). For dierentiation analysis, cells were incubated with primary antibody followed by Texas Red-conjugated antimouse IgGs. Fluorescence was analysed on epi¯uorescent microscope able to discriminate between rhodamine (SSEA-3 and VINIS-53) and green¯uorescent proteins (EGFP, EGFp27 or EGF-p21).
Apoptosis assay
For TUNEL assay, cells were treated with an in situ cell detection kit, according to the manufacturers instructions (Boehringer Mannheim Biochemicals). Nuclei with fragmented DNA were visualized by Fast Red staining.
